109 related articles for article (PubMed ID: 7288818)
1. Synthesis of fluorine-containing peptides. Analogues of angiotensin II containing hexafluorovaline.
Vine WH; Hsieh KH; Marshall GR
J Med Chem; 1981 Sep; 24(9):1043-7. PubMed ID: 7288818
[TBL] [Abstract][Full Text] [Related]
2. Long-acting angiotensin II inhibitors containing hexafluorovaline in position 8.
Hsieh KH; Needleman P; Marshall GR
J Med Chem; 1987 Jun; 30(6):1097-100. PubMed ID: 3585907
[TBL] [Abstract][Full Text] [Related]
3. Alkylating angiotensin II analogues: synthesis, analysis, and biological activity of angiotensin II analogues containing the nitrogen mustard melphalan in position 8.
Hsieh K; Marshall GR
J Med Chem; 1981 Nov; 24(11):1304-10. PubMed ID: 7310805
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
Moore GJ; Oudeman EM; Ko D; Nystrom DM
J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of [beta-Malyl1]- and [beta-Malyl1, Leu8]-angiotensin II analogues.
Cordopatis P; Matsoukas J; Michel A; Janen J; Theodoropoulos D
Experientia; 1983 Apr; 39(4):353-5. PubMed ID: 6832307
[TBL] [Abstract][Full Text] [Related]
6. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
Hsieh KH; LaHann TR; Speth RC
J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
[TBL] [Abstract][Full Text] [Related]
7. A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II.
Scanlon MN; Matsoukas JM; Franklin KJ; Moore GJ
Life Sci; 1984 Jan; 34(4):317-21. PubMed ID: 6546405
[TBL] [Abstract][Full Text] [Related]
8. Conformational restriction of angiotensin II: cyclic analogues having high potency.
Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
[TBL] [Abstract][Full Text] [Related]
9. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ
Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
[TBL] [Abstract][Full Text] [Related]
12. Role of the C-terminal carboxylate in angiotensin II activity: alcohol, ketone, and ester analogues of angiotensin II.
Hsieh KH; Marshall GR
J Med Chem; 1986 Oct; 29(10):1968-71. PubMed ID: 3761315
[TBL] [Abstract][Full Text] [Related]
13. Novel synthesis of cyclic amide-linked analogues of angiotensins II and III.
Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Gatos D; Ganter R; Moore D; Moore GJ
J Med Chem; 1994 Sep; 37(18):2958-69. PubMed ID: 8071943
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological properties of [1-N4-dimethyl-asparagine]-angiotensin II.
Cordopatis P; Brison J; Dirkx J; Theodoropoulos D
Experientia; 1979 Jul; 35(7):849-50. PubMed ID: 477828
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
Khosla MC; Hall MM; Munoz-RamÃrez H; Khairallah PA; Bumpus FM
J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues.
Bennett JP; Snyder SH
Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
Paiva AC; Nouailhetas VL; Paiva TB
J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
[TBL] [Abstract][Full Text] [Related]
19. Requirements for angiotensin tachyphylaxis in smooth muscles.
Paiva TB; Miyamoto ME; Juliano L; Paiva AC
J Pharmacol Exp Ther; 1977 Aug; 202(2):294-300. PubMed ID: 886468
[TBL] [Abstract][Full Text] [Related]
20. Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion.
Bennett JP; Snyder SH
Eur J Pharmacol; 1980 Oct; 67(1):1-10. PubMed ID: 6252018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
